Encompass Health Corporation EHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.61B | 1.60B | 1.59B | 1.54B | 1.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.61B | 1.60B | 1.59B | 1.54B | 1.48B |
| Cost of Revenue | 905.70M | 886.40M | 882.40M | 865.60M | 849.40M |
| Gross Profit | 703.80M | 711.00M | 704.20M | 679.00M | 628.10M |
| SG&A Expenses | 74.90M | 77.30M | 73.40M | 88.20M | 71.00M |
| Depreciation & Amortization | 92.80M | 90.40M | 87.30M | 86.40M | 82.40M |
| Other Operating Expenses | 245.20M | 254.90M | 241.90M | 221.00M | 231.10M |
| Total Operating Expenses | 1.32B | 1.31B | 1.29B | 1.26B | 1.23B |
| Operating Income | 290.90M | 288.40M | 301.60M | 283.40M | 243.60M |
| Income Before Tax | 257.80M | 261.60M | 288.70M | 257.70M | 219.90M |
| Income Tax Expenses | 53.40M | 53.60M | 56.40M | 55.40M | 44.90M |
| Earnings from Continuing Operations | 204.40M | 208.00M | 232.30M | 202.30M | 175.00M |
| Earnings from Discontinued Operations | -800.00K | -600.00K | 15.90M | 800.00K | -400.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -53.70M | -53.50M | -53.70M | -57.00M | -48.10M |
| Net Income | 149.90M | 153.90M | 194.50M | 146.10M | 126.50M |
| EBIT | 290.90M | 288.40M | 301.60M | 283.40M | 243.60M |
| EBITDA | 383.70M | 378.80M | 388.90M | 369.80M | 326.00M |
| EPS Basic | 1.52 | 1.55 | 1.96 | 1.45 | 1.26 |
| Normalized Basic EPS | 1.11 | 1.13 | 1.17 | 1.04 | 0.89 |
| EPS Diluted | 1.50 | 1.54 | 1.93 | 1.43 | 1.24 |
| Normalized Diluted EPS | 1.10 | 1.12 | 1.15 | 1.02 | 0.87 |
| Average Basic Shares Outstanding | 98.30M | 98.80M | 99.20M | 100.20M | 100.50M |
| Average Diluted Shares Outstanding | 99.70M | 100.00M | 100.60M | 102.00M | 102.30M |
| Dividend Per Share | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 |
| Payout Ratio | 12.47% | 12.28% | 10.44% | 13.00% | 13.44% |